Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S7 pseudogene 4 (RPS7P4) is a non-functional segment of DNA that shares sequence homology with the functional ribosomal protein S7 gene (RPS7). As a pseudogene, it does not produce a protein nor participate directly in biological processes. RPS7P4 has no recognized biological function, disease association, or interaction with drugs. It should not be confused with ribosomal protein S7, which is an essential structural protein of the eukaryotic 40S ribosomal subunit that catalyzes protein synthesis and is related to several diseases (such as Diamond-Blackfan anemia)[1][3]. RPS7P4 is not a therapeutic target, enzyme, receptor, transporter, nor does it have any established biological role—it is a pseudogene[1][3][4]. RPS7, in contrast, is a ribosomal protein involved in translation and associated with genetic diseases, but these attributes do not apply to RPS7P4[1][3][7]. This entry is considered incorrect as a therapeutic target due to its status as a pseudogene rather than a protein-coding gene[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S7 pseudogene 4 (RPS7P4).